Stay updated on Tideglusib in Congenital Myotonic Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page.

Latest updates to the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page
- CheckyesterdayChange DetectedThe web page has undergone significant updates, including the addition of new resources related to genetic diseases and drug safety, while removing previous references to certain locations and genetic conditions.SummaryDifference3%
- Check9 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.3%
- Check16 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.4%
- Check23 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check30 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
- Check37 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.2%
Stay in the know with updates to Tideglusib in Congenital Myotonic Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page.